A human drug metabolism database: Potential roles in the quantitative predictions of drug metabolism and metabolism-related drug-drug interactions

Current Drug Metabolism

Volumn 4, Issue 5, 2003, Pages 411-422

  Erhardt, Paul W ^a  

^a UNIVERSITY OF TOLEDO   (United States)

Author keywords

3D chemical structure; Bioinformatics; Chemoinformatics; Database; Drug drug interactions; Human drug metabolism

Indexed keywords

CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 3A; DEBRISOQUINE; PHENYTOIN; XENOBIOTIC AGENT;

BIOINFORMATICS; CHEMICAL STRUCTURE; COMPUTER PROGRAM; CROSS REACTION; DATA BASE; DRUG CONFORMATION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG EXCRETION; DRUG HALF LIFE; DRUG INFORMATION; DRUG METABOLISM; HUMAN; IMAGE DISPLAY; IN VITRO STUDY; IN VIVO STUDY; INTERNET; REVIEW; STRUCTURE ACTIVITY RELATION; THREE DIMENSIONAL IMAGING; XENOBIOTIC METABOLISM;

DATABASES, FACTUAL; DRUG INTERACTIONS; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; PREDICTIVE VALUE OF TESTS; STRUCTURE-ACTIVITY RELATIONSHIP; XENOBIOTICS;

EID: 0142061139     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389200033489299     Document Type: Review

References (62)

1. Darvas, F. (1987) in QSAR in Environmental Toxicology II, (Kaiser, K.L. Ed.) Reidel, Dordrecht, pp. 71-81.
2. Darvas, F. (1988) J. Mol. Graphics, 6, 80-86.
3. Commercially available from ComGenex, Inc.
4. Klopman, G.; Dimayuga, M. and Talafous, J. (1994) J. Chem. Inform. Comp. Sci., 34, 1320-1325.
5. Talafous, J.; Sayre, L.M.; Mieyal, J.J. and Klopman, G. (1994) J. Chem. Inf. Comp. Sci., 34, 1326-1333.
6. Klopman, G. and Tu, M. (1997) J. Chem, Inf. Comp. Sci., 37, 329-339.
7. Commercially available from MULTICASE, Inc.
8. Gifford, E.M.; Johnson, M.A. and Tsai, C.-c. (1994) Molecular Connections: The MDL Newsletter for Communicating with Customers, 13, 12-13.
9. Metabolite database is available from JDL Information Systems, Inc.
10. Hayward, J. (1999) in Drug Metabolism: Databases and High Throughput Testing During Drug Design and Development, (Erhardt, P. Ed.) IUPAC, Chapel Hill, pp. 281-288.
11. Commercially available from Accelrys, Ltd.
12. Hawkins, D.R. (1989-1995) Biotransformations: A Survey Of The Biotransformations Of Drugs And Chemicals In Animals, Vol. 1-8, The Royal Society of Chemistry, London.
13. Greene, N. (1999) in Drug Metabolism: Databases and High Throughput Testing During Drug Design and Development, (Erhardt, P. Ed.) IUIPAC, Chapel Hill, pp. 289-296.
14. Commercially available from LHASA, U.K.
15. Drug Metabolism: Databases and High Throughput Testing During Drug Design and Development (1999), (Erhardt, P. Ed.) IUPAC, Chapel Hill.
16. DiBiasio, K.W. (1989) Univ. Micro. Int., Univ. CA, Davis.
17. Baron, J.; Voigt, J.M.; Whitter, T.B.; Kawabata, T.T.; Knapp, S.A.; Guengerich, F.P. and Jakoby, W.B. (1986) Adv. Exp. Med. Biol., 197, 119-144.
18. Bachmann, K.; Pardoe, D. and White, D. (1996) Env. Health Persp., 104, 400-407.
19. Sarver, J.; White, D.; Erhardt, P. and Bachmann, K. (1997) Env. Health Persp., 105, 1204-1209.
20. Hayashi, S.; Watanabe, J. and Kawajiri, K. (1991) J. Biochem. (Tokyo), 110, 559-565.
21. Sugimura, H.; Caporaso, N.H.; Shaw, G.L.; Modali, R.V.; Gonzalez, F.J.; Hoover, R.N.; Resau, J.H.; Trump, B.F.; Weston, A. and Harris, C.C. (1990) Carcinogenesis, 11, 1527-1530.
22. Kato, S.; Onda, M.; Matsukura, N.; Tokunaga, A.; Tajiri, T.; Kim, D.Y.; Tsuruta, H.; Matsuda, N.; Yamashita, K. and Shields, P.G. (1995) Pharmacogenetics, 5, S141-S144.
23. Tominaga, K.; Koyama, Y.; Sasagawa, M.; Hiroki, M. and Nagai, M. (1991) Jpn. J. Cancer Res., 82, 974-979,
24. Borman, S. (1997) C & E. News, Feb., 43-62.
25. This phrase is being considered for adoption by the International Union of Pure and Applied Chemistry's nomenclature working party on Drug Metabolism Terms being chaired by P.W. Erhardt.
26. Erhardt, P. (1998) Medicinal Chem. Res., 8, 400-421.
27. Hann, M. and Green, R. (1999) Curr. Opin. Chem. Biol., 3, 379-383.
28. Ertl, P.; Miltz, W.; Rohde, B. and Selzer, P. (2000) Drug Discov. World, 1(2),45-50.
29. ChemFinder at www.chemfinder.com; Chem Navigator at www.chemnavigator.com; Info Chem GmbH at www.infochem.com; Institute for Scientific Info. at www.isinet.com; MDL Information Systems at www.mdli.com; MSI at www.msi.com; Oxford Molecular at www.oxmol.com; Pharmacopeia at www.pharmacopeia.com; QsarIS at www.scivision.com/qsaris.html; Synopsys Scientific Systems at www.synopsys.co.uk; Tripos at www.tripos.com.
30. Personal communications while attending numerous workshops directed toward expediting drug development.
31. Karet, G. (2001) Drug Discov. Develop., Jan., 28-32.
32. Brown, F.K. (1998) Ann. Rep. Med Chem., 33, 375-384.
33. ChemPen 3D at http://home.ici.net/~hfevans/chempen.htm; CS Chem Draw and CS Chem Draw 3D at www.camsoft.com; Corina. at www.mol-net.de.
34. Nezlin, A. (1999) Chem. News. Com., 9, 24-25.
35. Endres, M. (1992) Today's Chem. At Work, Oct., 30-44.
36. Karet, G. (2000) Drug Discov. Develop., Aug./Sep., 42-48.
37. QUANTA (system for determining 3D protein structure from x-ray data) and FELIX (system for determining 3D protein structure from NMR data) available from MSI-Pharmacopeia (www.msi.com).
38. Erhardt, P. (2002) Pure and Applied Chem., 74 (5), 703-785.
39. Hayton, W.L. (1980) J. Pharmacokin. Biopharm., 8, 321-334.
40. Ladd, B. (2000) Modern Drug Discov., Jan./Feb., 46-52.
41. Venkatsubramanian V. (1996) in Genetic Algorithms in Molecular Modeling, (Devillers, J. Ed.) Academic Press, New York, pp. 65-75.
42. Globus, A. (1999) Nanotechnology 10(3), 290-299.
43. Studt, T. (2000) Drug Discov. Develop., Aug./Sep., 30-36.
44. Resnick, R. (2000) Drug Discov. Develop., Oct., 51-52.
45. Jaen-Oltra, J.; Salabert-Salvador, T.; Garcia-March, F.J.; Perez-Gemenez, F. and Tohmas-Vert, F. (2000) J. Med. Chem., 43, 1143-1148.
46. Bio Reason at www.bioreason.com; Columbus Molecular Software (Lead Scope) at www.columbus-molecular.com; Daylight Chemical Information Systems at www.daylight.com; IBM (Intelligent Miner) at www.ibm.com; Incyte (Life Tools and Life Prot) at www.incyte.com; Molecular Applications (Gene Mine 3.5.1) at www.mag.com; Molecular Simulations at www.msi.com; Oxford Molecular (DIVA 1.1) at www.oxmol.com, Pangea Systems (Gene World 3.5) at www.pangeasystems.com; Pharsight at www.pharsight.com; SAS Institute (Enterprise Miner) at www.sas.com; SGI (Mine Set 3.0) at www.sgi.com; Spotfire (Spotfire Pro 4.0 and Leads Discover) at www.spotfire.com; SPSS (Clementine) at www.spss.com; Tripos at www.tripos.com.
47. Johnson, M.A.; Gifford, E. and Tsai, C.-C. (1990) in Concepts and Applications of Molecular Similarity, (Johnson, M.A. Ed.) John Wiley & Sons, New York, pp. 289-320.
48. Gifford, E.; Johnson, M. and Tsai, C.-C. (1991) J. Comput. Aided Mol. Des., 5, 303-322.
49. Gifford, E.M.; Johnson, M.A.; Kaiser, D.G. and Tsai, C.-C. (1992) J. Chem. Inf. Comp. Sci., 32, 591-599.
50. Gifford, E.M., Johnson, M.A.; Kaiser, D.G. and Tsai, C.-C. (1995) Xenobiolica, 25, 125-146.
51. Gifford, E.M. (1996) Applications of Molecular Similarity Methods to Visualize Xenobiotic Metabolism Structure-Reactivity Relationships, Ph.D. Thesis, Univ. Toledo.
52. Andrews, K.M. and Cramer, R.D. (2000) J. Med. Chem., 43, 1723-1740.
53. Borowski, T.; Krol, M.; Broclawik, E.; Baranowski, T.C.; Strekowski, L. and Mokrosz, M.J. (2000) J. Med. Chem., 43, 1901-1909.
54. Wintner, E.A. and Moallemi, C.C. (2000) J. Med. Chem., 43, 1933-2006.
55. Wrotnowski, C. (1999) Modern Drug Discov., Nov./Dec., 46-55.
56. Henry, C.M. (2000) Chem. Engin. News, Nov., 22-26.
57. Wedin, R. (1999) Modern Drug Discov., Sep./Oct., 39-47.
58. Gifford, E.M.; Johnson, M.A.; Kaiser, D.G. and Tsai, C.-C. (1994) SAR and QSAR in Environ. Res., 2 105-127.
59. Erhardt, P. (1999) in Drug Metabolism Databases and High-Throughput Testing During Drug Design and Development, (Erhardt, P. Ed.), IUPAC, Chapel Hill, pp. 185-191.
60. Erhardt, P. (1999) in Drug Metabolism Databases and High-Throughput Testing During Drug Design and Development, (Erhardt, P. Ed.), IUPAC, Chapel Hill, p. 320.
61. Erhardt, P. (2002) in High-Throughput ADMETox Estimation, (Darvas, F. and Dorman, G. Eds.), Easton Publishing, Westborough, pp. 41-48.
62. Recent results from this laboratory, Liao, J. (2000) Development Of Soft Drugs For The Neonatal Population, M.S. Thesis Univ. Toledo.